Furthermore, a complex interaction between inflammation and NAFLD has been shown among children with obesity, for which inflammatory cytokines, such as IL-1β, IL-6 and IL-17, have been recently described as markers for NAFLD risk [34]. Here, IL17A is linked to metabolic dysfunction-associated steatotic liver disease.